ENTRY       D11190                      Drug
NAME        Vosoritide (USAN/INN);
            Vosoritide (genetical recombination) (JAN);
            Voxzogo (TN)
PRODUCT     VOSORITIDE (BioMarin Pharmaceutical)
FORMULA     C176H290N56O51S3
EXACT_MASS  4100.0983
MOL_WEIGHT  4102.7254
SEQUENCE    PGQEHPNARK YKGANKKGLS KGCFGLKLDR IGSMSGLGC
            (Disulfide bridge: 23-39)
  TYPE      Peptide
REMARK      Therapeutic category: 3999
            ATC code: M05BX07
            Product: D11190<JP/US>
EFFICACY    Achondroplasia therapeutic agent
  DISEASE   Achondroplasia [DS:H01749]
COMMENT     Treatment of Achondroplasia
            modified recombinant human C-type natriuretic peptide (CNP)
TARGET      NPR2 [HSA:4882] [KO:K12324]
  PATHWAY   hsa04022(4882)  cGMP-PKG signaling pathway
            hsa04270(4882)  Vascular smooth muscle contraction
            hsa04921(4882)  Oxytocin signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M05 DRUGS FOR TREATMENT OF BONE DISEASES
               M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
                M05BX Other drugs affecting bone structure and mineralization
                 M05BX07 Vosoritide
                  D11190  Vosoritide (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Vosoritide
               D11190  Vosoritide (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D11190  Vosoritide (USAN/INN); Vosoritide (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Lyases (EC4)
               Phosphorus-oxygen lyases
                NPR2
                 D11190  Vosoritide (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11190
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11190
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11190
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11190
DBLINKS     CAS: 1480724-61-5
            PubChem: 384585169
///
